top of page

Phase 1/2 rGBM

(SDT-202)

SonALAsense is now recruiting for a Phase 1/2 dose escalation and expansion study of sonodynamic therapy with SONALA-001 in combination with Exablate 4000 Type 2.0 MR-Guided
Focused Ultrasound (MRgFUS) in subjects with progressive or recurrent glioblastoma multiforme
(rGBM)

For more details regarding the study design, please visit our ClinicalTrials.gov listing: 

https://www.clinicaltrials.gov/ct2/show/NCT05370508

This trial is now recruiting, Contact Us to learn more about eligibility.

bottom of page